GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolase Inc (NAS:BIOL) » Definitions » E10

Biolase (Biolase) E10 : $-2,901.34 (As of Dec. 2023)


View and export this data going back to 1992. Start your Free Trial

What is Biolase E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biolase's adjusted earnings per share data for the three months ended in Dec. 2023 was $-6.532. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-2,901.34 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was 3.10% per year. During the past 5 years, the average E10 Growth Rate was 3.40% per year. During the past 10 years, the average E10 Growth Rate was 3.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Biolase was 46.30% per year. The lowest was -19.60% per year. And the median was 2.80% per year.

As of today (2024-04-28), Biolase's current stock price is $0.148. Biolase's E10 for the quarter that ended in Dec. 2023 was $-2,901.34. Biolase's Shiller PE Ratio of today is .


Biolase E10 Historical Data

The historical data trend for Biolase's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolase E10 Chart

Biolase Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,626.01 -3,189.07 -3,211.15 -3,310.29 -2,901.34

Biolase Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,310.29 -3,246.57 -3,160.01 -3,003.07 -2,901.34

Competitive Comparison of Biolase's E10

For the Medical Devices subindustry, Biolase's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biolase's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolase's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biolase's Shiller PE Ratio falls into.



Biolase E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biolase's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-6.532/129.4194*129.4194
=-6.532

Current CPI (Dec. 2023) = 129.4194.

Biolase Quarterly Data

per share eps CPI Adj_EPS
201403 -1,525.380 99.695 -1,980.187
201406 -1,994.730 100.560 -2,567.204
201409 -938.697 100.428 -1,209.681
201412 -938.697 99.070 -1,226.264
201503 -1,056.030 99.621 -1,371.906
201506 -1,408.050 100.684 -1,809.912
201509 -1,056.030 100.392 -1,361.378
201512 -469.349 99.792 -608.692
201603 -821.360 100.470 -1,058.022
201606 -704.023 101.688 -896.017
201609 -1,056.030 101.861 -1,341.738
201612 -821.360 101.863 -1,043.561
201703 -750.000 102.862 -943.637
201706 -1,525.000 103.349 -1,909.688
201709 -750.000 104.136 -932.098
201712 -525.000 104.011 -653.249
201803 -625.000 105.290 -768.235
201806 -600.000 106.317 -730.380
201809 -575.000 106.507 -698.699
201812 -825.000 105.998 -1,007.294
201903 -575.000 107.251 -693.854
201906 -450.000 108.070 -538.901
201909 -625.000 108.329 -746.677
201912 -325.000 108.420 -387.947
202003 -475.000 108.902 -564.494
202006 -300.000 108.767 -356.962
202009 -525.000 109.815 -618.725
202012 -175.000 109.897 -206.088
202103 -138.000 111.754 -159.814
202106 -12.000 114.631 -13.548
202109 -54.000 115.734 -60.385
202112 -75.000 117.630 -82.517
202203 -81.000 121.301 -86.421
202206 -91.980 125.017 -95.219
202209 -110.360 125.227 -114.055
202212 -128.000 125.222 -132.291
202303 -18.000 127.348 -18.293
202306 -8.930 128.729 -8.978
202309 -3.890 129.860 -3.877
202312 -6.532 129.419 -6.532

Add all the adjusted EPS together and divide 10 will get our e10.


Biolase  (NAS:BIOL) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Biolase E10 Related Terms

Thank you for viewing the detailed overview of Biolase's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Biolase (Biolase) Business Description

Traded in Other Exchanges
Address
27042 Towne Centre Drive, Suite 270, Lake Forest, CA, USA, 92610
Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.
Executives
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Lord Jonathan T Md director 500 WEST MAIN ST., LOUISVILLE KY 40202
Jennifer Bright officer: Chief Financial Officer 27042 TOWNE CENTRE DRIVE,, SUITE 270, FOOTHILL RANCH CA 92610
Steven Sandor officer: Chief Operating Officer 27042 TOWNE CENTRE DRIVE,, SUITE 270, FOOTHILL RANCH CA 92610
Jess Roper director 5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Kenneth P. Yale director 27042 TOWN CENTRE DRIVE, SUITE 270, FOOTHILL RANCH CA 92610
John R Beaver director, officer: President & CEO C/O STERLING CHEMICALS INC, 1200 SMITH STREET, HOUSTON TX 77002
Kathleen T Oloughlin director 27042 TOWN CENTRE DRIVE, SUITE 270, FOOTHILL RANCH CA 92610
Somerman Martha J. Dds, Phd director 27042 TOWN CENTRE DRIVE, SUITE 270, FOOTHILL RANCH CA 92610
Summerhays Carol Gomez Dds director 27042 TOWN CENTRE DRIVE, SUITE 270, FOOTHILL RANCH CA 92610
Family Foundation Schuler 10 percent owner 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Larry N Feinberg 10 percent owner C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
Jack W Schuler 10 percent owner 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Michael Ditolla director 3299 CAMBRIDGE AVE, BRONX NY 10463